Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

NCT00283829 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: docetaxel
DRUG: IL2

Sponsor

University of Washington

Collaborators

[object Object]